Medivir: CMD takeaways
Research Note
2020-03-03
09:14
Following yesterday’s CMD we feel a growing conviction in MIV-818, which was the main attraction of the day, and Redeye reiterates our base case of SEK 30.
KP
Klas Palin
Disclosures and disclaimers